JournalsHub
.online
Find My Journal
TK

Terufumi Kato

Kanagawa Prefectural Hospital Organization JP

ORCID iD 0000-0002-5853-1424
514
Publications
29,634
Citations
58
H-Index
168
i10-Index
16.56
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

510 total

Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer PDF

Heather A. Wakelee, Moïshe Liberman, Terufumi Kato, Masahiro Tsuboi, Se‐Hoon Lee et al. - New England Journal of Medicine, 2023
Cited by 971 OpenAlex

Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation PDF

Ferdinandos Skoulidis, Bob T. Li, Grace K. Dy, Timothy Price, Gerald S. Falchook et al. - New England Journal of Medicine, 2021
Cited by 1,709 OpenAlex

Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer PDF

Yi‐Long Wu, Masahiro Tsuboi, Jie He, Thomas John, Christian Grohé et al. - New England Journal of Medicine, 2020
Cited by 1,711 OpenAlex

Tepotinib in Non–Small-Cell Lung Cancer with <i>MET</i> Exon 14 Skipping Mutations PDF

Paul K. Paik, Enriqueta Felip, Rémi Veillon, Hiroshi Sakai, Alexis B. Cortot et al. - New England Journal of Medicine, 2020
Cited by 841 OpenAlex

Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer PDF

Luis Paz‐Ares, Alexander Luft, David Vicente, Ali Tafreshi, Mahmut Gümüş et al. - New England Journal of Medicine, 2018
Cited by 3,612 OpenAlex

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

James Chih‐Hsin Yang, Yi‐Long Wu, Martin Schüler, Martin Sebastian, Sanjay Popat et al. - The Lancet Oncology, 2015
Cited by 1,576 OpenAlex

Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study

Takashi Seto, Terufumi Kato, Makoto Nishio, Kōichi Goto, Shinji Atagi et al. - The Lancet Oncology, 2014
Cited by 748 OpenAlex

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations

Lecia V. Sequist, James Chih‐Hsin Yang, Nobuyuki Yamamoto, Kenneth J. O’Byrne, Vera Hirsh et al. - Journal of Clinical Oncology, 2013
Cited by 3,190 OpenAlex

Research Topics

Lung Cancer Treatments and Mutations (337) Lung Cancer Diagnosis and Treatment (130) Lung Cancer Research Studies (128) Cancer Immunotherapy and Biomarkers (102) Colorectal Cancer Treatments and Studies (80)

Affiliations

Ulsan College
KR 2021 - 2021
Hebron University
PS 2020 - 2020
Memorial Sloan Kettering Cancer Center
US 2021 - 2021
Université Toulouse III - Paul Sabatier
FR 2018 - 2018
University of Tsukuba
JP 2019 - 2019

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now